Overall The mission of the Center for AIDS Research (CFAR) at Emory University is to decrease HIV incidence, improve well-being and, ultimately, find a vaccine and a cure for HIV by fostering and supporting trans- disciplinary research targeting the Southern epidemic as a microcosm of the global HIV/AIDS pandemic. The Emory CFAR has been extremely successful in strategically expanding a University-wide, multidisciplinary community of scientists whose NIH-funded research has led to globally recognized interventions that prevent new HIV transmissions and enhance the wellbeing of people living with and at risk for HIV. Over its 18-year history, the Emory CFAR has become the cornerstone of Emory's HIV research community and has brought the University to world prominence as a center of excellence in HIV/AIDS research. During the current project period the Emory CFAR Executive Leadership maintained a focus on immunology and pathogenesis while also greatly expanding the CFAR's capacity to provide innovative and comprehensive clinical, prevention science, and biostatistical support to HIV researchers. We have also strengthened our ties with the community through substantive partnerships with community-based, state, and national public health agencies that are focusing attention on the Southern HIV epidemic. The CFAR's success in providing Value Added to Emory University is widely acknowledged by the University leadership that has committed $3M in institutional support for the CFAR from the offices of the Emory University President, Provost, and all five units of the Woodruff Health Science Center (Emory School of Medicine, Rollins School of Public Health, Nell Hodgson Woodruff School of Nursing, Winship Cancer Institute, and Yerkes National Primate Research Center). In addition, the Georgia Research Alliance, an external partner that promotes the growth of research in Georgia, continues their commitment to support the CFAR through the purchase of research equipment and funds for laboratory infrastructure needs. As a means of fulfilling the mission of the CFAR we propose specifically to 1) Develop, support, and expand high priority HIV/AIDS research that will prevent new infections, improve the well-being of people with or at risk for HIV, and move toward the discovery of a vaccine and a cure; 2) Translate and disseminate HIV/AIDS research findings; 3) Identify, train, mentor, and support the next generation of HIV/AIDS researchers and scientific leaders. In this way we are confident that the Emory CFAR will continue to build on its successes to develop a comprehensive research program that makes significant contributions to ending the HIV epidemic. This application is for a Center for AIDS Research award.
In the 21st century the mitigation of suffering from HIV/AIDS remains a global challenge. The mission of the Center for AIDS Research (CFAR) at Emory University is to decrease HIV incidence, improve well-being and, ultimately, find a vaccine and a cure for HIV by fostering and supporting trans-disciplinary research targeting the Southern US epidemic as a microcosm of the global HIV/AIDS pandemic. This project will foster career development of young HIV investigators and provide innovative and comprehensive HIV research support services for new and established researchers through five science cores ? Clinical Research, Prevention Science, Biostatistics & Bioinformatics, Immunology, and Virology & Molecular Biomarkers ? and two scientific working groups: HIV & Aging and HIV Cure.
|Lassiter, Jonathan M; Saleh, Lena; Starks, Tyrel et al. (2017) Race, Ethnicity, Religious Affiliation, and Education Are Associated With Gay and Bisexual Men's Religious and Spiritual Participation and Beliefs: Results From the One Thousand Strong Cohort. Cultur Divers Ethnic Minor Psychol :|
|Kapwata, Thandi; Morris, Natashia; Campbell, Angela et al. (2017) Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa. PLoS One 12:e0181797|
|Chen, Zhe; Cox, Bryan D; Garnier-Amblard, Ethel C et al. (2017) Synthesis and anti-HCV activity of a series of ?-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs. Bioorg Med Chem Lett 27:5296-5299|
|Zlotorzynska, Maria; Sullivan, Patrick; Sanchez, Travis (2017) The Annual American Men's Internet Survey of Behaviors of Men Who Have Sex With Men in the United States: 2015 Key Indicators Report. JMIR Public Health Surveill 3:e13|
|Mittendorf, Kathleen F; Marinko, Justin T; Hampton, Cheri M et al. (2017) Peripheral myelin protein 22 alters membrane architecture. Sci Adv 3:e1700220|
|Gigante, Adriano M; Hampton, Cheri M; Dillard, Rebecca S et al. (2017) The Ms6 Mycolyl-Arabinogalactan Esterase LysB is Essential for an Efficient Mycobacteriophage-Induced Lysis. Viruses 9:|
|Linton, Sabriya L; Haley, Danielle F; Hunter-Jones, Josalin et al. (2017) Social causation and neighborhood selection underlie associations of neighborhood factors with illicit drug-using social networks and illicit drug use among adults relocated from public housing. Soc Sci Med 185:81-90|
|Parsons, Jeffrey T; Rendina, H Jonathon; Lassiter, Jonathan M et al. (2017) Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States. J Acquir Immune Defic Syndr 74:285-292|
|Winhusen, Theresa; Feaster, Daniel J; Duan, Rui et al. (2017) Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection. AIDS Behav :|
|Siegler, Aaron J; Wirtz, Susan; Weber, Shannon et al. (2017) Developing a Web-Based Geolocated Directory of HIV Pre-Exposure Prophylaxis-Providing Clinics: The PrEP Locator Protocol and Operating Procedures. JMIR Public Health Surveill 3:e58|
Showing the most recent 10 out of 902 publications